Clinical Development Contamination Contract Manufacturing Manufacturing 
The Pharma Data
JANUARY 27, 2021
The two-hour event will cover various topics, including an overview of the Company’s board and executive leadership, its commitment to environment, social and governance (ESG) matters, and progress updates on the Company’s critical care programs, manufacturing and distribution approach, and commercial readiness plans. About MultiStem ®.
The Pharma Data
NOVEMBER 15, 2020
MultiStem ® cell therapy is a patented regenerative medicine product candidate in clinical development that has shown the ability to promote tissue repair and healing in a variety of ways, such as through the production of therapeutic factors in response to signals of inflammation and tissue damage. About MultiStem ®.
Expert insights. Personalized for you.
52 
Let's personalize your content